 |
|
Advances in liver surgery enable the prospect of curative treatment for more patients
June 15, 2009Although many prognostic factors predicting survival and cancer recurrence in patients undergoing surgery for colorectal liver metastases are already identified, the effects of newly introduced technologies and new drugs in the treatment of these patients are still poorly studied because of the presence of many involved factors.
A research article to be published on June 7, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Professor Josep Fuster and Dr. Josep Marti from Hospital Clinic in Barcelona (Spain) reviewed their patients undergoing surgery for colorectal liver metastases from 1994 to 2006 to study the changes during two different time periods. As various studies have shown better operative outcomes and advances in patient selection and treatments in recent times, the article further investigated the results of all these changes on patient survival and cancer recurrence.
The study analyzed prognostic factors and found that patients with extrahepatic disease, high levels of carcinoembriogenic antigen (a commonly used tumor marker for colorectal cancer patients' surveillance) or more than 4 nodules were at risk of a poorer survival. Patient survival at 5-years after surgery was 47%. It was seen that patients in the second time period had more adverse prognostic factors and a shorter hospital stay than in the first period but no differences in overall survival and recurrence were observed between the two periods.
Although prognostic factors for survival and cancer recurrence of patients undergoing surgery for colorectal liver metastases are important for the selection of the best treatment options, improvements in surgical technique and better complementary treatments in recent times allow for the increase in the number of patients benefiting from surgical curative treatment. However, a careful patient selection and the judicious use of other available treatments prior to and after surgery are crucial to improve prognosis in these patients.
Professor Josep Fuster and Dr. Josep Marti are currently working at the Liver Surgery and Transplantation Unit at Hospital Clinic in Barcelona (Spain), a well known Institution for its leading advances and publications in liver and gastrointestinal diseases.
World Journal of Gastroenterology
Although prognostic factors for survival and cancer recurrence of patients undergoing surgery for colorectal liver metastases are important for the selection of the best treatment options, improvements in surgical technique and better complementary treatments in recent times allow for the increase in the number of patients benefiting from surgical curative treatment. However, a careful patient selection and the judicious use of other available treatments prior to and after surgery are crucial to improve prognosis in these patients.
Professor Josep Fuster and Dr. Josep Marti are currently working at the Liver Surgery and Transplantation Unit at Hospital Clinic in Barcelona (Spain), a well known Institution for its leading advances and publications in liver and gastrointestinal diseases.
World Journal of Gastroenterology
Prognostic Factors Current Events and Prognostic Factors News RSSPET imaging response a prognostic factor after thoracic radiation therapy for lung cancer
A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting.
Research needed to learn which DCIS patients may be candidates for less invasive therapy
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood.
Ultrasound can predict tumor burden and survival in melanoma patients
Researchers have shown for the first time that patterns of ultrasound signals can be used to identify whether or not cancer has started to spread in melanoma patients, and to what extent. The discovery enables doctors to decide on how much surgery, if any, is required and to predict the patient's probable survival.
Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic hepatitis C?
It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others.
Is molecular adsorbent recirculating system effective for all the liver failure patients?
Since its introduction in 1993, molecular adsorbent recirculating system (MARS) albumin dialysis has been a subject of research, with the hope of treating effectively patients with acute liver failure.
Two targeted therapies likely better than one in patients with aggressive lymphoma
When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG).
Study points toward relationship between cancer stem cells and prognosis in primary breast cancer
Breast cancer patients who received chemotherapy prior to surgery had heightened levels of cancer-initiating stem cells in their bone marrow, and the level of such cells correlated to a tumor's lymph node involvement, according to research from The University of Texas M. D. Anderson Cancer Center.
Survival predictors may help customize treatment options for men with metastatic prostate cancer
Four risk factors that help predict how long men may survive with metastatic prostate cancer could help doctors choose more effective treatments, according to a study led by researchers in the Duke Comprehensive Cancer Center.
New universal breast cancer marker predicts recurrence and clinical outcome
Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer patient survival.
How to increase the efficacy of local excision of rectal cancer
With the advancement of imaging techniques, the accuracy of preoperative rectal cancer staging has increased dramatically, and the preservation of physical function in rectal cancer patients has become a very important aim of research.
More Prognostic Factors Current Events and Prognostic Factors News Articles
 |
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating (Statistics for Biology and Health) by Ewout W. Steyerberg (Author) This book aims to provide insight and practical illustrations on how modern statistical concepts and regression methods can be applied in medical prediction problems, including diagnostic and prognostic outcomes. Many advances have been made in statistical approaches towards outcome prediction, but these innovations are insufficiently applied in medical research. Old-fashioned, data hungry methods are often used in data sets of limited size, validation of predictions is not done or only in a simplistic way, and updating of already available models is not considered. A sensible strategy is needed for model development, validation, and updating, such that prediction models can better support medical practice. Clinical Prediction Models presents a practical checklist with seven... |
|
PROGNOSTIC FACTORS IN BREAST CANCER by A.P.M. FORREST AND P.B. KUNKLER (Author) | |
 |
Exploring Differences in Breast Cancer Prognostic Factors - Health Disparities between Caucasian and African-American Women in the United States by Sriya Krishnamoorthy (Author) The purpose of this study is to explore how differences in breast cancer prognostic factors contribute to the diminished survival rate of African-American women in the United States with breast cancer. Relative to Caucasian women, African-American women were found to be diagnosed with breast cancer at younger ages, with more aggressive tumor histology, and at more advanced stages. Age at diagnosis was found to be the most predictive factor for survival, where African-American women were almost two times more likely to be diagnosed with breast cancer before the age of 40 years. Differences in breast cancer age at diagnosis, histology, and stage are present by race. However, a unified effort from community leaders, public health educators, and clinical professionals to target underserved... |
|
Key estrogen receptor gene mutation discovered. (Clinical Rounds: May be exploitable as a prognostic factor).(Brief Article): An article from: Internal Medicine News by Bruce Jancin (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on April 1, 2002. The length of the article is 2913 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Key estrogen receptor gene mutation discovered. (Clinical Rounds: May be exploitable as a prognostic factor).(Brief Article) Author: Bruce Jancin Publication: Internal Medicine News (Magazine/Journal) Date: April 1, 2002 Publisher: International Medical News Group Volume: 35 Issue: 7 Page: 24(1) Article Type: Brief Article Distributed by... | |
|
Menstrual timing of surgery not seen as prognostic factor.(Women's Health): An article from: Family Practice News by International Medical News Group (Publisher) This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2005. The length of the article is 416 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Menstrual timing of surgery not seen as prognostic factor.(Women's Health) Publication: Family Practice News (Magazine/Journal) Date: February 1, 2005 Publisher: International Medical News Group Volume: 35 Issue: 3 Page: 49(1) Distributed by Thompson... | |
|
A study of prognostic factors in sudden hearing loss.: An article from: Ear, Nose and Throat Journal by Aydin Mamak (Author), Suleyman Yilmaz (Author), Harun Cansiz (Author), Ender Inci (Author), Ender Guclu (Author), Levent Derekoylu (Author) This digital document is an article from Ear, Nose and Throat Journal, published by Thomson Gale on October 1, 2005. The length of the article is 3375 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: A study of prognostic factors in sudden hearing loss. Author: Aydin Mamak Publication: Ear, Nose and Throat Journal (Magazine/Journal) Date: October 1, 2005 Publisher: Thomson Gale Volume: 84 Issue: 10 Page: 641(4) Distributed by Thomson... | |
 |
Acute Leukemias VIII: Prognostic Factors and Treatment Strategies (Haematologie Und Bluttransfusion) (v. 8) by T. Buchner (Editor), W. Hiddemann (Editor), B. Wormann (Editor), G. Schellong (Editor), J. Ritter (Editor), U. Creutzig (Editor) Univ. of Munster, Germany. Presents the rapid progress in the medical understanding of leukemia and the identification of novel therapeutic approaches for the disease. Coverage includes first-hand reports from leading study groups and the latest updates on multicenter trials of new therapies. DNLM: Leukemia--Therapy. |
|
Melanoma Staging Criteria To Reflect Current Practice: Drop Clark's level as prognostic factor. (TO BE RELEASED NEXT SPRING).: An article from: Skin & Allergy News by Sherry Boschert (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on November 1, 2001. The length of the article is 694 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Melanoma Staging Criteria To Reflect Current Practice: Drop Clark's level as prognostic factor. (TO BE RELEASED NEXT SPRING). Author: Sherry Boschert Publication: Skin & Allergy News (Magazine/Journal) Date: November 1, 2001 Publisher: International Medical News Group Volume: 32 Issue: 11 Page: 1(2) Distributed by Thomson... | |
![Prognostic factors for chronic neck pain in persons with Minor or moderate injuries in traffic accidents [An article from: Accident Analysis and Prevention]](http://ecx.images-amazon.com/images/I/51MWCV1HX3L._SL160_.jpg) |
Prognostic factors for chronic neck pain in persons with Minor or moderate injuries in traffic accidents [An article from: Accident Analysis and Prevention] by E. Pape (Author), J.I. Brox (Author), K.B. Hagen (Author), B. Natvig (Author), Schirme (Author) This digital document is a journal article from Accident Analysis and Prevention, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: Prognostic factors for chronic neck pain were identified in a prospective Norwegian insurance cohort comprising 636 persons with minor or moderate traffic injuries. One questionnaire was used at baseline and another at 3 years post-injury. Daily severe or very severe neck pain at three years follow up was defined as chronic neck pain. Eight significant independent prognostic factors for chronic neck pain were identified: (1) rear-end or frontal and rear-end collision, odds ratio (OR): 4.10 (95%... |
|
Cancer therapy: Prognostic factors and criteria of response ([Monograph of the European Organization for Research on Treatment of Cancer ; v. 1]) by Raven Press (Publisher) |
| © 2009 BrightSurf.com |